PHARMOS made a net profit of CZK 11.2 mil with revenues of CZK 10,337 mil in 2019, up by 128% and up by 1.62%, respectively, compared to the previous year. This translates into a net margin of 0.108%.
Historically, between 2006 - 2019, the firm’s net profit reached a high of CZK 44.3 mil in 2016 and a low of CZK -27.0 mil in 2012. Since 2014, the firm's net profit has increased 89.5% or 13.6% a year on average.
On the operating level, EBITDA reached CZK 57.5 mil, up 21.6% compared to the previous year. Over the last five years, company's EBITDA has risen 4.91% a year on average.
You can see all the company’s data at PHARMOS profile, or you can download a report on the company in the report section.
Helgi Library 
